zolmitriptan intracutaneous microneedle system (C213) / Zosano  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zolmitriptan intracutaneous microneedle system (C213) / Zosano
ADAM, NCT03282227: A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine

Completed
3
342
US
M207 Microneedle System, ZP-Zolmitriptan Intracutaneous Microneedle System, ADAM-Zolmitriptan
Zosano Pharma Corporation
Migraine
05/19
05/19
Zotrip, NCT02745392: Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine

Completed
2/3
365
US
ZP-Zolmitriptan, Placebo
Zosano Pharma Corporation
Acute Migraine
01/17
01/17
NCT04066023: Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches

Completed
2/3
42
US
C213 Microneedle System, Zolmitriptan Microneedle System, Placebo, ZP Placebo
Zosano Pharma Corporation
Cluster Headache
04/21
04/21

Download Options